Aberrant methylation of the THRB gene in tissue and plasma of breast cancer patients

Cancer Genetics and Cytogenetics

Volumn 196, Issue 2, 2010, Pages 140-145

  Ling, Yaqin ^a,b   Xu, Xiaoying ^b   Hao, Jie ^c   Ling, Xiaoling ^b   Du, Xiaopin ^c   Liu, Xin ^b   Zhao, Xingxu ^a  

^a GANSU AGRICULTURAL UNIVERSITY   (China)

^b LANZHOU UNIVERSITY   (China)

^c Department of Breast   (China)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; THYROID HORMONE RECEPTOR BETA; THYROID HORMONE RECEPTOR BETA 1; UNCLASSIFIED DRUG;

ADULT; AGAR GEL ELECTROPHORESIS; AGED; ARTICLE; BREAST; BREAST CANCER; CONTROLLED STUDY; CPG ISLAND; GENE EXPRESSION; GENE FREQUENCY; GENE LOCATION; GENE LOSS; GENE SEQUENCE; GENE SILENCING; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC DISORDER; HUMAN; HUMAN TISSUE; PLASMA; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN METHYLATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS;

BASE SEQUENCE; BREAST NEOPLASMS; CPG ISLANDS; DNA METHYLATION; DNA PRIMERS; ELECTROPHORESIS, AGAR GEL; FEMALE; GENES, ERBA; HUMANS; PROMOTER REGIONS, GENETIC; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 71649086659     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cancergencyto.2009.09.010     Document Type: Article

References (32)

1. Mangelsdorf D.J., Thummel C., Beato M., Herrlich P., Schütz G., Umesono K., Blumberg B., Kastner P., Mark M., Chambon P., and Evans R.M. The nuclear receptor superfamily: the second decade. Cell 83 (1995) 835-839
2. Muñoz A., and Bernal J. Biological activities of thyroid hormone receptors. Eur J Endocrinol 137 (1997) 433-445
3. Bauer M.S., and Whybrow P.C. Thyroid hormones and the central nervous system in affective illness: interactions that may have clinical significance. Integr Psychiatry 6 (1988) 75-100
4. García-Silva S., and Aranda A. The thyroid hormone receptor is suppressor of ras-mediated transcription, proliferation, and transformation. Mol Cell Biol 24 (2004) 7514-7523
5. Hörkkö T.T., Tuppurainen K., George S.M., Jernvall P., Karttunen T.J., and Mäkinen M.J. Thyroid hormone receptor β1 in normal colon and colorectal cancer: association with differentiation, polypoid growth type and K- ras mutation. Int J Cancer 118 (2006) 1653-1659
6. Hsieh M.L., and Juang H.H. Cell growth effects of triiodothyronine and expression of thyroid hormone receptor in prostate carcinoma cell. J Androl 26 (2005) 422-428
7. Silva J.M., Domínguez G., González-Sancho J.M., García J.M., Silva J., García-Andrade C., Navarro A., Muñoz A., and Bonilla F. Expression of thyroid hormone receptor/ erbA genes is altered in human breast cancer. Oncogene 21 (2002) 4307-4316
8. Conde I., Paniagua R., Zamora J., Blánquez M.J., Fraile B., Ruiz A., and Arenas M.I. Influence of thyroid hormone receptors on breast cancer cell proliferation. Ann Oncol 17 (2006) 60-64
9. Neville M.C., McFadden T.B., and Forsyth I. Hormonal regulation of mammary differentiation and milk secretion. J Mammary Gland Biol Neoplasia 7 (2002) 49-66
10. Saraiva P.P., Figueiredo N.B., Padovani C.R., Brentani M.M., and Nogueira C.R. Profile of thyroid hormones in breast cancer patients. Braz J Med Biol Res 38 (2005) 761-765
11. Beatson G.T. On the treatment of inoperable cancer of the mamma: suggestions for a new method of treatment with illustrative cases. Lancet 2 (1896) 104-165
12. Burke R.E., and McGuire W.L. Nuclear thyroid hormone receptors in a human breast cancer cell line. Cancer Res 38 (1978) 3769-3773
13. Li Z., Alboladejo V., Joly-Pharaboz M.O., Nicolas B., and Andre J. Antiestrogens prevent the stimulatory effects of l-triiodothyronine on cell proliferation. Endocrinology 130 (1992) 1145-1152
14. Smyth P.P.A. The thyroid and breast cancer: a significant association?. Ann Med 29 (1997) 189-191
15. Yokoe T., Iino I., Takei H., Horiguchi J., Koibuchi Y., Maemura M., Ohwade S., and Morishita Y. Relationship between thyroid-pituitary function and response to therapy in patients with recurrent breast cancer. Anticancer Res 16 (1996) 2069-2072
16. Yokoe T., Iino I., Takei H., Horiguchi J., Koibuchi Y., Maemura M., Ohwade S., and Morishita Y. Changes of cytokines and thyroid function in patients with recurrent breast cancer. Anticancer Res 17 (1997) 695-699
17. Gosden J.R., Middleton P.G., Rout D., and De Angelis C. Chromosomal localization of the human oncogene ERBA2. Cytogenet Cell Genet 43 (1986) 150-153
18. Drabkin H., Kao F.T., Hartz J., Hart I., Gazdar A., Weinberger C., Evans R., and Gerber M. Localization of human ERBA2 to the 3p22-3p24.1 region of chromosome 3 and variable deletion in small cell lung cancer. Proc Natl Acad Sci U S A 85 (1988) 9258-9262
19. Thompson C.C., Weinberger C., Lebo R., and Evans R.M. Identification of a novel thyroid hormone receptor expressed in the mammalian central nervous system. Science 237 (1987) 1610-1614
20. Li Z., Meng Z.H., Chandrasekaran R., Kuo W.L., Collins C.C., Gray J.W., and Dairkee S.H. Biallelic inactivation of the thyroid hormone receptor β1 gene in early stage breast cancer. Cancer Res 62 (2002) 1939-1943
21. Joseph B., Ji M., Liu D., Hou P., and Xing M. Lack of mutations in the thyroid hormone receptor (TR) α and β genes but frequent hypermethylation of the TRβ gene in differentiated thyroid tumors. J Clin Endocrinol Metab 92 (2007) 4766-4770
22. Belinsky S.A. Gene-promoter hypermethylation as a biomarker in lung cancer. Nat Rev Cancer 4 (2004) 707-717
23. Esteller M., Sanchez-Cespedes M., Rosell R., Sidransky D., Baylin S.B., and Herman J.G. Detection of aberrant promoter hypermethylation of tumor suppressor genes in serum DNA from non-small cell lung cancer patients. [Erratum in: Cancer Res 1999;59:3853]. Cancer Res 59 (1999) 67-70
24. Pfeifer G.P., and Dammann R. Methylation of the tumor suppressor gene RASSF1A in human tumors. Biochemistry (Mosc) 70 (2005) 576-583
25. Wallin G., Brönnegård M., Grimelius L., McGuire J., and Tørring O. Expression of the thyroid hormone receptor, the oncogenes c- myc and H- ras, and the 90 kD heat shock protein in normal, hyperplastic, and neoplastic human thyroid tissue. Thyroid 2 (1992) 307-313
26. Brönnegård M., Törring O., Böös J., Sylven C., Marcus C., and Wallin G. Expression of thyrotropin receptor and thyroid hormone receptor messenger ribonucleic acid in normal, hyperplastic, and neoplastic human thyroid tissue. Clin Endocrinol Metab 79 (1994) 384-389
27. Puzianowska-Kuznicka M., Krystyniak A., Madej A., Cheng S.Y., and Nauman J. Functionally impaired TR mutants are present in thyroid papillary cancer. Clin Endocrinol Metab 87 (2002) 1120-1128
28. Markowitz S., Haut M., Stellato T., Gerbic C., and Molkentin K. Expression of the ErbA-beta class of thyroid hormone receptors is selectively lost in human colon carcinoma. J Clin Invest 84 (1989) 1683-1687
29. Lin K.H., Lin Y.W., Lee H.F., Liu W.L., Chen S.T., Chang K.S.S., and Cheng S.Y. Increased invasive activity of human hepatocellular carcinoma cells is associated with an overexpression of thyroid hormone β1 nuclear receptor and low expression of the anti-metastatic nm23 gene. Cancer Lett 98 (1995) 89-95
30. Issa J.P. CpG-island methylation in aging and cancer. Curr Top Microbiol Immunol 249 (2000) 101-118
31. Wong I.H., Lo Y.M., and Johnson P.J. Epigenetic tumor markers in plasma and serum: biology and applications to molecular diagnosis and disease monitoring. Ann N Y Acad Sci 945 (2001) 36-50
32. INK4a is an early event in lung cancer and a potential biomarker for early diagnosis. Proc Natl Acad Sci U S A 95 (1998) 11891-11896